Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
Commentary|Articles|August 7, 2026
Q&A: Prepare for FDA Inspection on Compounded GLP-1s
Fact checked by: Ron Panarotti
Pharmacists can guide patients in verifying sources, identifying licensed pharmacies, and understanding compounded vs FDA-approved products.
Advertisement
Advertisement
Annie Lambert, PharmD, BCSCP, compliance program manager at Wolters Kluwer Health, discussed the shifting regulatory landscape around compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and what it means for pharmacists. She explained that by excluding GLP-1s from the 503B bulk compounding list, the FDA is signaling a narrower role for widespread compounding of agents like semaglutide (Ozempic, Wegovy; Novo Nordisk), tirzepatide (Mounjaro, Zepbound; Eli Lilly and Company), and liraglutide (Victoza, Saxenda; Novo Nordisk), while 503A pharmacies face increased scrutiny.
Related to this article
Pharmacists can work alongside dermatologists, nurses, other health care professionals to help answer skincare-related questions and help patients understand trial outcomes.
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
ADA guidance ties monitoring choices to therapy, risk, and preference. Brooke Hudspeth, PharmD, explains how pharmacists help individualize the plan.
The provider-administered IL-23 inhibitor improved ACR20 response vs placebo after 2 doses in the phase 3 INSPIRE-1 and INSPIRE-2 trials.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
Advertisement
Advertisement